https://www.selleckchem.com/pr....oducts/tolebrutinib-
9% vs. 6.0%, p = 0.026) and time to oral intake (5.0 (4.0-7. day vs. 5.0 (3.0-6. day, p = 0.036). Operative time, conversion rate, postoperative stay, and proportion of reoperation, Clavien-Dindo classification, 30-day readmission and 90-day mortality were similar in two groups. In elderly patients, when compared with OPD, LPD had the advantage of shorter time to start oral intake (5.0 (4.0-7. day vs. 7.0 (5.0-11.3) day, p = 0.005) but the disadvantage of longer operative time (380.0 (306.3-447.5) min vs. 292.5 (255
Like
Comment
Share
